Joint (JYNT) Expected to Announce Earnings on Thursday

Key Points

• Joint (NASDAQ:JYNT) is expected to report quarterly earnings for Q2 2025 on August 7th, forecasting earnings of ($0.07) per share and revenue of $13.32 million.
• The company has initiated a $5.00 million stock buyback program, suggesting leadership views its shares as undervalued.
• Lake Street Capital has reduced Joint's target price from $20.00 to $16.00, while maintaining a "buy" rating on the stock.

Joint (NASDAQ:JYNT - Get Free Report) is expected to be announcing its Q2 2025 earnings results after the market closes on Thursday, August 7th. Analysts expect Joint to post earnings of ($0.07) per share and revenue of $13.32 million for the quarter.

Joint (NASDAQ:JYNT - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by ($0.01). Joint had a negative net margin of 9.86% and a positive return on equity of 1.60%. The company had revenue of $13.08 million during the quarter, compared to analysts' expectations of $13.02 million. On average, analysts expect Joint to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Joint Price Performance

Shares of JYNT stock traded up $0.10 during mid-day trading on Monday, hitting $11.03. The stock had a trading volume of 12,769 shares, compared to its average volume of 59,153. The company's 50-day simple moving average is $11.39 and its 200-day simple moving average is $11.11. The firm has a market cap of $168.79 million, a PE ratio of -19.14 and a beta of 1.53. Joint has a fifty-two week low of $9.58 and a fifty-two week high of $13.47.

Joint declared that its board has approved a share repurchase program on Thursday, June 5th that permits the company to buyback $5.00 million in outstanding shares. This buyback authorization permits the company to repurchase up to 2.7% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its stock is undervalued.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital cut their price target on shares of Joint from $20.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, May 9th.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.